Ibrutinib is safer than we think

Slupsky, Joseph R ORCID: 0000-0002-7410-9004 (2019) Ibrutinib is safer than we think. BLOOD, 133 (19). pp. 2006-2007.

Text
Commentary JSlupsky Ibrutinib is safer that we think.pdf - Author Accepted Manuscript
Download (665kB) | Preview

Official URL: http://dx.doi.org/10.1182/blood-2019-03-901009

Abstract

Ibrutinib works, but does using it set patients up for potential relapse by causing increased genomic instability? This question is addressed in this issue of Blood by Morande et al, who provide convincing evidence that resolves a key safety issue surrounding the use of this drug, giving new insight into its mechanism of action.

Item Type:	Article
Uncontrolled Keywords:	Humans, Piperidines, Pyrazoles, Pyrimidines, Adenine, Leukemia, Lymphocytic, Chronic, B-Cell
Depositing User:	Symplectic Admin
Date Deposited:	10 May 2019 15:39
Last Modified:	19 Jan 2023 00:46
DOI:	10.1182/blood-2019-03-901009
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3040583